Literature DB >> 10874523

Immunosuppression in older renal transplant patients.

J M Morales1, J M Campistol, A Andrés, J C Herrero.   

Abstract

Renal transplantation procedures in patients older than 60 years of age have clearly improved in recent years. In the cyclosporin era, graft and patient survival are good. However, older patients exhibit a higher mortality, especially from infectious and cardiovascular causes, than young patients. In this article we review the immunosuppressive treatment in older patients, analyse what drugs can be used and finally propose several immunosuppressive combinations to treat this group of patients. Currently, new immunosuppressive drugs enable more flexible immunosuppressive protocols. Nevertheless, to avoid overimmunosuppression, elderly patients should be treated with lower doses and fewer immunosuppressive drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874523     DOI: 10.2165/00002512-200016040-00004

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  50 in total

1.  Kidney transplantation in patients between 65 and 75 years of age.

Authors:  I Fehrman; C Brattstrom; F Duraj; C G Groth
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

2.  Use of antithymocyte globulin for reversal of acute allograft rejection.

Authors:  C F Shield; A B Cosimi; N Tolkoff-Rubin; R H Rubin; J Herrin; P S Russell
Journal:  Transplantation       Date:  1979-12       Impact factor: 4.939

3.  Renal transplantation in patients over 55 years old.

Authors:  G Lauffer; J A Murie; D Gray; A Ting; P J Morris
Journal:  Br J Surg       Date:  1988-10       Impact factor: 6.939

4.  One-hundred and five cadaveric kidney transplants with cyclosporine in recipients more than 60 years of age.

Authors:  D Cantarovich; T Baranger; A Tirouvanziam; R Baatard; J N Le Sant; J Dantal; M Hourmant; G Karam; J P Soulillou
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.

Authors:  J M Morales; M A Muñoz; C Campo; A Andres; A Araque; C Alamo; M Praga; T Ortuño; E Hernandez; J L Rodicio
Journal:  Transplant Proc       Date:  1994-10       Impact factor: 1.066

Review 6.  The therapeutic use of azathioprine in renal transplantation.

Authors:  G L Chan; D M Canafax; C A Johnson
Journal:  Pharmacotherapy       Date:  1987       Impact factor: 4.705

7.  A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.

Authors:  J D Pirsch; J Miller; M H Deierhoi; F Vincenti; R S Filo
Journal:  Transplantation       Date:  1997-04-15       Impact factor: 4.939

8.  Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.

Authors: 
Journal:  Transplantation       Date:  1996-03-15       Impact factor: 4.939

9.  Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age.

Authors:  J D Pirsch; R J Stratta; M J Armbrust; A M D'Alessandro; H W Sollinger; M Kalayoglu; F O Belzer
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

10.  A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; S Mitchell
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

View more
  5 in total

Review 1.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  Renal transplantation in the elderly.

Authors:  Ramesh Saxena; Xueqing Yu; Mauricio Giraldo; Juan Arenas; Miguel Vazquez; Christopher Y Lu; Nosratola D Vaziri; Fred G Silva; Xin J Zhou
Journal:  Int Urol Nephrol       Date:  2008-11-07       Impact factor: 2.370

3.  Modulation of human peripheral blood mononuclear cell proliferative response by diltiazem : in vitro comparison in younger versus older subjects.

Authors:  Antonella D'Ambrosio; Luciana Giordani; Manuela Colucci; Nicola Vanacore; Francesca Quintieri
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients.

Authors:  Giulia Angeloni; Miriam Latteri; Raffaele Manna; Carlo Rumi; Giovanni Gasbarrini; Pierluigi Navarra
Journal:  Eur J Clin Pharmacol       Date:  2004-03-26       Impact factor: 2.953

Review 5.  Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.

Authors:  Dirk R J Kuypers
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.